Metabolic syndrome and coronary heart disease among Spanish male workers: A case-control study of MESYAS

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 6, 2012, Pages 510-516

  Laclaustra, M ^a   Ordonez B ^b   Leon, M ^b   Andres, E M ^c   Cordero, A ^d   Pascual Calleja, I ^b   Grima, A ^e   Luengo, E ^b   Alegria, E ^f   Pocovi, M ^b,g   Civeira, F ^b,g   Casasnovas Lenguas, J A ^b,g  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^e Preventive Cardiology   (Spain)

^f Policlínica Gipuzkoa ^*  (Spain)

^g UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Cardiovascular risk; Case control study; Coronary heart disease; Hypertriglyceridemia; Male gender; Metabolic syndrome

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CORONARY ARTERY DISEASE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; RISK; RISK ASSESSMENT; RISK FACTOR; SPAIN; STATISTICAL MODEL;

ADULT; AGED; CASE-CONTROL STUDIES; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OVERWEIGHT; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 84861185925     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.09.009     Document Type: Article

References (39)

1. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117(4):e25-e146.
2. Cabades O'Callaghan A. [The REGICOR registry and the epidemiology of myocardial infarction in Spain: forging a path]. Rev Esp Cardiol 2007, 60(4):342-345.
3. Cristobal J., Lago F., de la Fuente J., Gonzalez-Juanatey J.R., Vazquez-Belles P., Vila M. [Comparison of coronary risk estimates derived using the Framingham and REGICOR equations]. Rev Esp Cardiol 2005, 58(8):910-915.
4. Tomas Abadal L., Varas Lorenzo C., Perez I., Puig T., Balaguer Vintro I. [Risk factors and coronary morbimortality in a Mediterranean industrial cohort over 28 years of follow-up. The Manresa Study]. Rev Esp Cardiol 2001, 54(10):1146-1154.
5. Masia R., Pena A., Marrugat J., Sala J., Vila J., Pavesi M., et al. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. J Epidemiol Community Health 1998, 52(11):707-715.
6. Medrano M.J., Cerrato E., Boix R., Delgado-Rodriguez M. [Cardiovascular risk factors in Spanish population: metaanalysis of cross-sectional studies]. Med Clin (Barc) 2005, 124(16):606-612.
7. Marrugat J., D'Agostino R., Sullivan L., Elosua R., Wilson P., Ordovas J., et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health 2003, 57(8):634-638.
8. Marrugat J., Subirana I., Comin E., Cabezas C., Vila J., Elosua R., et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study. J Epidemiol Community Health 2007, 61(1):40-47.
9. Girman C.J., Rhodes T., Mercuri M., Pyorala K., Kjekshus J., Pedersen T.R., et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 2004, 93(2):136-141.
10. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24(4):683-689.
11. Malik S., Wong N.D., Franklin S.S., Kamath T.V., L'Italien G.J., Pio J.R., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004, 110(10):1245-1250.
12. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288(21):2709-2716.
13. Hunt K.J., Resendez R.G., Williams K., Haffner S.M., Stern M.P. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004, 110(10):1251-1257.
14. Wassink A.M., van der Graaf Y., Olijhoek J.K., Visseren F.L. Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2008, 29(2):213-223.
15. Alegria E., Cordero A., Laclaustra M., Grima A., Leon M., Casasnovas J.A., et al. [Prevalence of metabolic syndrome in the Spanish working population: MESYAS registry]. Rev Esp Cardiol 2005, 58(7):797-806.
16. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the study of obesity. Circulation 2009, 120(16):1640-1645.
17. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D.S., Haffner S.M., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003, 108(4):414-419.
18. Wannamethee S.G., Shaper A.G., Lennon L., Morris R.W. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005, 165(22):2644-2650.
19. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005, 28(7):1769-1778.
20. Galassi A., Reynolds K., He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006, 119(10):812-819.
21. Gami A.S., Witt B.J., Howard D.E., Erwin P.J., Gami L.A., Somers V.K., et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007, 49(4):403-414.
22. Ninomiya J.K., L'Italien G., Criqui M.H., Whyte J.L., Gamst A., Chen R.S. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004, 109(1):42-46.
23. Wilson P.W., D'Agostino R.B., Parise H., Sullivan L., Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005, 112(20):3066-3072.
24. Lorenzo C., Williams K., Hunt K.J., Haffner S.M. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007, 30(1):8-13.
25. Ballantyne C.M., Hoogeveen R.C., McNeill A.M., Heiss G., Schmidt M.I., Duncan B.B., et al. Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study. Int J Obes (Lond) 2008, 32(Suppl. 2):S21-S24.
26. Wannamethee S.G. The metabolic syndrome and cardiovascular risk in the British Regional Heart Study. Int J Obes (Lond) 2008, 32(Suppl. 2):S25-S29.
27. Wang J.J., Li H.B., Kinnunen L., Hu G., Jarvinen T.M., Miettinen M.E., et al. How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population?. Atherosclerosis 2007, 192(1):161-168.
28. de Simone G., Devereux R.B., Chinali M., Best L.G., Lee E.T., Galloway J.M., et al. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. Diabetes Care 2007, 30(7):1851-1856.
29. Hu G., Qiao Q., Tuomilehto J., Balkau B., Borch-Johnsen K., Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004, 164(10):1066-1076.
30. Ford E.S. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004, 173(2):309-314.
31. Eberly L.E., Prineas R., Cohen J.D., Vazquez G., Zhi X., Neaton J.D., et al. Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial. Diabetes Care 2006, 29(1):123-130.
32. Tortosa A., Bes-Rastrollo M., Sanchez-Villegas A., Basterra-Gortari F.J., Nunez-Cordoba J.M., Martinez-Gonzalez M.A. Mediterranean diet inversely associated with the incidence of metabolic syndrome: the SUN prospective cohort. Diabetes Care 2007, 30(11):2957-2959.
33. Esposito K., Marfella R., Ciotola M., Di Palo C., Giugliano F., Giugliano G., et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004, 292(12):1440-1446.
34. Salas-Salvado J., Fernandez-Ballart J., Ros E., Martinez-Gonzalez M.A., Fito M., Estruch R., et al. Effect of a mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. Arch Intern Med 2008, 168(22):2449-2458.
35. Kahn R. The Metabolic Syndrome (Emperor) wears no clothes. Diabetes Care 2006, 29(7):1693-1696.
36. Laclaustra M., Corella D., Ordovas J.M. Metabolic syndrome pathophysiology: the role of adipose tissue. Nutr Metab Cardiovasc Dis 2007, 17(2):125-139.
37. Guize L., Pannier B., Thomas F., Bean K., Jego B., Benetos A. Recent advances in metabolic syndrome and cardiovascular disease. Arch Cardiovasc Dis 2008, 101(9):577-583.
38. Farin H.M., Abbasi F., Reaven G.M. Comparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individuals. Am J Cardiol 2006, 98(8):1053-1056.
39. Assmann G., Schulte H., Seedorf U. Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study. Int J Obes (Lond) 2008, 32(Suppl. 2):S11-S16.